Table 2.
Mean (SD) values of Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in the total group and in the Relapsing Remitting (RR) and Progressive (P) subgroups
| |
Baseline |
1 month |
3 months |
6 months |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | RR | P | Total | RR | P | Total | RR | P | Total | RR | P | |
| MSSES-Function |
66.45 (21.52) |
81.80 (12.15) |
53.59 (19.62) |
66.28 (21.29) |
81.70 (12.52) |
54.09 (19.31) |
64.47 (22.41) |
74.75 (19.33) |
54.23 (20.28) |
66.10 (21.93) |
81.30 (12.00) |
50.94 (18.07) |
| MSSES-Control |
47.79 (19.06) |
57.01 (19.67) |
41.63 (15.29) |
49.33 (17.42) |
58.04 (15.01) |
43.84 (16.24) |
49.64 (19.76) |
53.52 (18.28) |
45.50 (20.77) |
55.05 (18.91) |
64.26 (13.66) |
46.18 (19.44) |
| IPA-Limitations |
2.70 (0.57) |
2.43 (0.57) |
2.89 (0.50) |
2.59 (0.63) |
2.34 (0.53) |
2.76 (0.65) |
2.57 (0.62) |
2.26 (0.51) |
2.85 (0.56) |
2.58 (0.67) |
2.30 (0.55) |
2.88 (0.64) |
| IPA-Problems | 2.09 (0.36) | 1.95 (0.36) | 2.17 (0.32) | 1.97 (0.46) | 1.73 (0.39) | 2.11 (0.43) | 1.93 (0.52) | 1.74 (0.48) | 2.07 (0.54) | 2.02 (0.51) | 1.86 (0.52) | 2.14 (0.48) |